NRGENE TECHNOLOGIES LTD (IL:NRGN)
TASE:NRGN
Want to see IL:NRGN full AI Analyst Report?
NRGN Stock Chart & Stats
204.80
0.03(0.96%)
At close: 4:00 PM EST
204.80
0.03(0.96%)
Day’s Range― - ―
52-Week Range190.80 - 390.00
Previous CloseN/A
Volume1.26K
Average Volume (3M)27.56K
Market Cap
₪29.61M
Enterprise Value7.25M
Total Cash (Recent Filing)₪5.30M
Total Debt (Recent Filing)₪181.00K
Price to Earnings (P/E)―
Beta0.53
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,327,785
10 Day Avg. Volume57,803
30 Day Avg. Volume27,561
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.94
Price to Sales (P/S)2.64
P/FCF Ratio116.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Top-line Rebound & Margin ImprovementA sharp revenue inflection (+251% in 2025) combined with a material gross margin improvement (~60.6%) indicates meaningful improvement in unit economics and product-market traction. If sustained, this supports scalable revenue growth and a clearer path to operating leverage and eventual profitability over months.
Improving Cash GenerationOperating cash flow turned positive in 2025 and free cash flow reached slight positive territory after years of burn, signaling improved cash conversion. Durable positive cash generation reduces near-term dilution risk and gives management optionality to invest in growth or reduce reliance on external financing.
Low Financial LeverageVery low debt relative to equity provides financial flexibility to fund operations or growth without heavy interest burden. Conservative leverage lowers insolvency risk during continued investment cycles and gives the company runway to execute strategic initiatives while losses persist.
Bears Say
Persistent Large LossesDespite top-line gains, operating and net margins remain deeply negative (~-47%), showing the company has not yet translated revenue growth into profitability. Continued large losses can erode equity, constrain reinvestment, and require sustained improvement in margins to achieve durable financial viability.
Small, Volatile Free Cash FlowFree cash flow is minimal and has been volatile, declining materially year-over-year despite operating improvements. Small, inconsistent FCF limits ability to self-fund growth, increases dependence on external capital, and raises execution risk if revenue or margins slip in coming quarters.
Negative Returns And Equity VolatilityA highly negative ROE demonstrates shareholder capital is being eroded rather than rewarded. Historical equity volatility and past negative equity episodes imply a risk of future dilution or recapitalization if losses continue, undermining long-term shareholder value even if top-line recovers.
NRGN FAQ
What was NRGENE TECHNOLOGIES LTD’s price range in the past 12 months?
NRGENE TECHNOLOGIES LTD lowest stock price was 190.80 and its highest was 390.00 in the past 12 months.
What is NRGENE TECHNOLOGIES LTD’s market cap?
NRGENE TECHNOLOGIES LTD’s market cap is ₪29.61M.
When is NRGENE TECHNOLOGIES LTD’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NRGENE TECHNOLOGIES LTD’s earnings last quarter?
Currently, no data Available
Is NRGENE TECHNOLOGIES LTD overvalued?
According to Wall Street analysts NRGENE TECHNOLOGIES LTD’s price is currently Overvalued.
Does NRGENE TECHNOLOGIES LTD pay dividends?
NRGENE TECHNOLOGIES LTD does not currently pay dividends.
What is NRGENE TECHNOLOGIES LTD’s EPS estimate?
NRGENE TECHNOLOGIES LTD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NRGENE TECHNOLOGIES LTD have?
NRGENE TECHNOLOGIES LTD has 13,327,785 shares outstanding.
What happened to NRGENE TECHNOLOGIES LTD’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NRGENE TECHNOLOGIES LTD?
Currently, no hedge funds are holding shares in IL:NRGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NRGENE TECHNOLOGIES LTD
NRGene Technologies Ltd is an AI-powered genomics firm that designs sophisticated computational tools and advanced algorithms, serving clients globally across North America, Europe, the Middle East, Africa, and Asia Pacific. The company provides specialized software applications and complete, ready-to-use solutions for various sectors, including agricultural breeding, food technology, academia, research institutions, and agribiotech enterprises. Additionally, NRGene develops custom genetic panels tailored for a broad range of plants, from staple crops like wheat, canola, corn, soybeans, and maize to cannabis. Established in 2009, its headquarters are located in Ness Ziona, Israel.